Salarius Pharmaceuticals Inc expected to post a loss of 9  cents a share - Earnings Preview

Decoy Therapeutics

06/05/2022 18:02

* Salarius Pharmaceuticals Inc  SLRX.OQ   SLRX.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 12. 
    * ​Refinitiv's mean analyst estimate for Salarius
Pharmaceuticals
Inc is for a loss of 9 cents per share. For the same quarter
last year, the company reported a loss of 6 cents per share.
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Salarius
Pharmaceuticals Inc is $4.25​, above​ its last closing price
of $0.21. ​​​

This summary was machine generated May 6 at 17:01 GMT.  All
figures in US dollars  unless otherwise stated